All In Biotech

Free tool

FAERS Monitor: Cuvposa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022571 or its brand name (Cuvposa, Glycopyrrolate). Reports on generic versions are filed under their own applications.

Reports

5,640

Serious

4,741

84% of reports

Hospitalization

2,392

Death reported

679

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,058
  • asthma853
  • wheezing719
  • cough670
  • pneumonia585
  • drug ineffective448
  • off label use387
  • fatigue376
  • malaise365
  • chronic obstructive pulmonary disease361
  • productive cough350
  • chest discomfort337
  • nausea337
  • condition aggravated325
  • therapeutic product effect incomplete317

Reports by year received

View as table
YearReports
200412
200514
200616
200730
200829
200946
201062
201174
201288
201371
2014128
2015148
2016230
2017434
2018300
2019325
2020289
2021462
2022632
2023573
2024611
2025672
2026393

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,519 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal71945.842.731,139
asthmaSignal85328.426.622,433
productive coughSignal35027.524.98,879
chronic obstructive pulmonary diseaseSignal36126.023.58,605
therapeutic product effect incompleteSignal31716.715.04,654
chest discomfortSignal33712.311.13,496
coughSignal6708.98.34,762
dyspnoeaSignal1,0587.06.65,555
pneumoniaSignal5856.76.22,898
condition aggravatedSignal3254.03.6735
malaiseSignal3653.12.8529
fatigue3761.81.6138
off label use3871.61.5102
nausea3371.61.476
drug ineffective4481.31.227

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.